478 related articles for article (PubMed ID: 16554257)
1. Contemporary assessment and pharmacotherapy of Tourette syndrome.
Scahill L; Erenberg G; Berlin CM; Budman C; Coffey BJ; Jankovic J; Kiessling L; King RA; Kurlan R; Lang A; Mink J; Murphy T; Zinner S; Walkup J;
NeuroRx; 2006 Apr; 3(2):192-206. PubMed ID: 16554257
[TBL] [Abstract][Full Text] [Related]
2. Clinical phenomenology and phenotype variability in Tourette syndrome.
Grados MA; Mathews CA
J Psychosom Res; 2009 Dec; 67(6):491-6. PubMed ID: 19913653
[TBL] [Abstract][Full Text] [Related]
3. [Clinical aspects of Tourette syndrome].
Debes NM; Hjalgrim H; Skov L
Ugeskr Laeger; 2008 Aug; 170(35):2701-3. PubMed ID: 18761861
[TBL] [Abstract][Full Text] [Related]
4. The relationship between tourette syndrome, attention deficit hyperactivity disorder, and stimulant medication: a critical review.
Erenberg G
Semin Pediatr Neurol; 2005 Dec; 12(4):217-21. PubMed ID: 16780292
[TBL] [Abstract][Full Text] [Related]
5. [Tourette syndrome: an analysis of its comorbidity and specific treatment].
Castellanos FX; Acosta MT
Rev Neurol; 2004 Feb; 38 Suppl 1():S124-30. PubMed ID: 15011166
[TBL] [Abstract][Full Text] [Related]
6. Association of cortical disinhibition with tic, ADHD, and OCD severity in Tourette syndrome.
Gilbert DL; Bansal AS; Sethuraman G; Sallee FR; Zhang J; Lipps T; Wassermann EM
Mov Disord; 2004 Apr; 19(4):416-25. PubMed ID: 15077239
[TBL] [Abstract][Full Text] [Related]
7. Self-, parent-, and teacher-reported behavioral symptoms in youngsters with Tourette syndrome: a case-control study.
Termine C; Selvini C; Balottin U; Luoni C; Eddy CM; Cavanna AE
Eur J Paediatr Neurol; 2011 Mar; 15(2):95-100. PubMed ID: 21273099
[TBL] [Abstract][Full Text] [Related]
8. Psychiatric disorders and behavioral problems in children and adolescents with Tourette syndrome.
Ghanizadeh A; Mosallaei S
Brain Dev; 2009 Jan; 31(1):15-9. PubMed ID: 18558469
[TBL] [Abstract][Full Text] [Related]
9. Psychopharmacotherapy of Obsessive-Compulsive Symptoms within the Framework of Tourette Syndrome.
Rothenberger A; Roessner V
Curr Neuropharmacol; 2019; 17(8):703-709. PubMed ID: 30152283
[TBL] [Abstract][Full Text] [Related]
10. Relationship of obsessive-compulsive disorder to age-related comorbidity in children and adolescents with Tourette syndrome.
Wanderer S; Roessner V; Freeman R; Bock N; Rothenberger A; Becker A
J Dev Behav Pediatr; 2012 Feb; 33(2):124-33. PubMed ID: 22261832
[TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacology of comorbid obsessive-compulsive disorder in Tourette syndrome.
Neri V; Cardona F
Int Rev Neurobiol; 2013; 112():391-414. PubMed ID: 24295628
[TBL] [Abstract][Full Text] [Related]
12. Chronic tics and Tourette syndrome in patients with obsessive-compulsive disorder.
Diniz JB; Rosario-Campos MC; Hounie AG; Curi M; Shavitt RG; Lopes AC; Miguel EC
J Psychiatr Res; 2006 Sep; 40(6):487-93. PubMed ID: 16289552
[TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapy of Tourette's syndrome and associated disorders.
Cohen DJ; Riddle MA; Leckman JF
Psychiatr Clin North Am; 1992 Mar; 15(1):109-29. PubMed ID: 1549543
[TBL] [Abstract][Full Text] [Related]
14. [Comorbid disorders associated with tics].
Fernández-Alvarez E
Rev Neurol; 2002 Feb; 34 Suppl 1():S122-9. PubMed ID: 12447802
[TBL] [Abstract][Full Text] [Related]
15. Validation of the presence of comorbidities in a Danish clinical cohort of children with Tourette syndrome.
Mol Debes NM; Hjalgrim H; Skov L
J Child Neurol; 2008 Sep; 23(9):1017-27. PubMed ID: 18827268
[TBL] [Abstract][Full Text] [Related]
16. Pharmacotherapy for tics in adult patients with Tourette syndrome and other tic disorders.
Badenoch J; Cavanna AE
Neurol Sci; 2020 Jul; 41(7):1923-1926. PubMed ID: 32170503
[TBL] [Abstract][Full Text] [Related]
17. N-Acetylcysteine in the Treatment of Pediatric Tourette Syndrome: Randomized, Double-Blind, Placebo-Controlled Add-On Trial.
Bloch MH; Panza KE; Yaffa A; Alvarenga PG; Jakubovski E; Mulqueen JM; Landeros-Weisenberger A; Leckman JF
J Child Adolesc Psychopharmacol; 2016 May; 26(4):327-34. PubMed ID: 27027204
[TBL] [Abstract][Full Text] [Related]
18. Understanding disability in Tourette syndrome.
Pringsheim T; Lang A; Kurlan R; Pearce M; Sandor P
Dev Med Child Neurol; 2009 Jun; 51(6):468-72. PubMed ID: 19018838
[TBL] [Abstract][Full Text] [Related]
19. Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experience.
Chappell PB; Riddle MA; Scahill L; Lynch KA; Schultz R; Arnsten A; Leckman JF; Cohen DJ
J Am Acad Child Adolesc Psychiatry; 1995 Sep; 34(9):1140-6. PubMed ID: 7559307
[TBL] [Abstract][Full Text] [Related]
20. Social and emotional adjustment in children affected with Gilles de la Tourette's syndrome: associations with ADHD and family functioning. Attention Deficit Hyperactivity Disorder.
Carter AS; O'Donnell DA; Schultz RT; Scahill L; Leckman JF; Pauls DL
J Child Psychol Psychiatry; 2000 Feb; 41(2):215-23. PubMed ID: 10750547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
